Keval Y. Raval

Keval Y. Raval

S

Profile ID RP-000-7330 Joined 2023-03-27 4 articles
0Connections
10
Total Views
4
Total Publications
53
Publication Views

Articles(4)

Authors: Bhargav K Kamani, Keval Y. Raval*

DOI: 10.18231/j.ijcaap.2023.004

Volume8
Issue1
Pages27-31
Abstract

Cancer refers to a category of illnesses characterised by uncontrolled growth of new cells. The screening of an anticancer drug is a time-consuming procedure that requires several in-vitro, in-vivo, and clinical investigations. Toxic dosages of screening pharmaceutical drugs in-vivo at varying concentrations need to be envisioned in order to prevent chemical poisoning in animals throughout an experiment. Cancer management has been the subject of several in-vitro and in-vivo investigations. To determine the test compound's anti-cancer efficacy, this research compiled a review of in vivo and in vitro assays. Here, the study emphasizes on the numerous preclinical approaches and processes used in anticancer research.   Keywords: Cancer, In­vivo, in­vitro, Anti­cancer drug, Screening methods

Authors: Rutvik Hirani, Keval Y. Raval*

DOI: 10.18231/j.ijcaap.2023.015

Volume8
Issue2
Pages86-90
Abstract

Diuretics are medications that aid in the elimination of excess urine. Water, electrolytes, and metabolic waste are all found in urine. The anatomy and physiology of the renal excretion system are the topics of the current study. Along with the reasonable diuretic activity it also highlights the kidney's involvement in renal excretion. The mechanism of several diuretic classes is connected to their active target site in this overview. Diuretics have previously demonstrated their clinical efficacy in treating conditions including hypertension, renal failure, nephritic syndrome, and others. Here, several in-vitro and screening models demonstrate their clinical relevance. The logical goal, experimental methods, and assessment criteria of diverse screening models of diuretic action are highlighted in the current study. It also highlights the value and significance of these screening methods for determining the efficacy and safety of various members of various types of diuretic medicines. This review also revealed how some screening model improvements were successful. Studying the diuretic potential of various drugs is therefore absolutely helpful. In the end, the current review establishes a robust framework for dosage modification and fatal impact research of diverse kinds of diuretics. Thus, this study provides some suggestions for choosing cutting-edge methods to check the activity of diuretics. It also exposes the effects of the creation and adjustment of these screening methods, making them more effective in the future for assessing the diuretic potential of various diuretics agents.   Keywords: In-vitro methods

Authors: Keval Y. Raval, Pravin Tirgar

DOI: 10.18231/j.ijpca.2023.015

Volume10
Issue2
Pages75-78
Abstract

This study provides a comprehensive overview of safety pharmacology practises, technologies, and emerging concepts in drug discovery and development. The field of safety pharmacology serves a crucial role in anticipating and minimising the hazards and adverse effects of new medications. Evaluation of important organ systems, such as the cardiovascular, central nervous, respiratory, gastrointestinal, and renal systems, is involved. While the main battery of safety pharmacology research focuses on major organ systems, additional studies may be done depending on the unique properties of prospective medications. The research emphasises the significance of evaluating the gastrointestinal and renal systems and addresses the many approaches, biomarkers, and technologies used to enhance safety evaluations. In addition, new ideas like as frontloading, alternative models, and the incorporation of safety pharmacology endpoints into regulatory toxicology studies are investigated. These developments help to better informed decision-making and lead candidate selection, eventually improving the safety and effectiveness of novel treatments. Keywords: Cardiovascular system (CVS), Central Nervous System (CNS), International Conference on Harmonization (ICH)

Authors: Yash Dhamsaniya, Keval Raval

DOI: 10.18231/j.ijpca.2023.016

Volume10
Issue2
Pages79-83
Abstract

Animal models play a critical role in diabetes research, aiding in the comprehension of both type 1 and type 2 diabetes pathogenesis and the assessment of potential therapeutic interventions. These models offer numerous advantages, including the ability to induce stable hyperglycemia and hyperlipidemia, minimal variability, and the opportunity to study genetic mutations and single gene effects. However, they also present limitations such as lengthy induction periods, fluctuating glucose parameters, potential toxicity to other organs, and high costs. Various screening models, encompassing in vitro assays and models like Alloxan-induced and Streptozotocin-induced diabetes, serve as valuable tools for investigating diabetes and testing drug efficacy. The selection of an appropriate model requires careful consideration of specific research objectives. Despite their limitations, animal models continue to be indispensable for advancing our understanding of diabetes and developing effective treatments. Keywords: Glibenclamide, hyperglycemia, Streptozotocin (STZ)

No matching articles

Try another word from the title, author or DOI.

Brief Bio

No bio added yet.

Affiliations

Nothing added yet.

Education

Nothing added yet.

Honors & Awards

Nothing added yet.

Society Memberships

Nothing added yet.

Expertise

Nothing added yet.

Specialty

Nothing added yet.

Other Online Pages

Followers(0)

Nobody here yet.

Following(0)

Nobody here yet.

4 Publications